Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-18

Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial evaluating Umbilical Cord Derived Mesenchymal Stem Cell Therapy for Systemic lupus erythematosus; the trial status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical cord-derived mesenchymal stem cell therapy (Umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Hebei Medical University | Conditions: Systemic Lupus Erythematosus | EARLY_Phase 1 | Status: UNKNOWN